Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks

Jesse Yenchih Hsu1,2, Jason A Roy1,2, Dawei Xie1,2

  • 1Department of Biostatistics and Epidemiology and.

Insights

Survival analysis in chronic kidney disease (CKD) must account for competing risks, where events like death can censor outcomes such as end-stage renal disease (ESRD). This study reviews methods to handle dependent censoring in CKD research.

Area of Science:

  • Nephrology
  • Biostatistics
  • Clinical Epidemiology

Background:

  • Survival analysis is crucial for evaluating outcomes like end-stage renal disease (ESRD) and mortality in chronic kidney disease (CKD) populations.
  • Traditional methods assume independent censoring, which is often violated in clinical settings due to competing risks such as death.
  • Dependent censoring, where a competing event influences the time to the event of interest, is common in CKD research.

Purpose of the Study:

  • To describe clinical scenarios in renal research involving competing risks.
  • To review statistical approaches for analyzing survival data with competing risks.
  • To compare cause-specific hazards models and the Fine and Gray approach for competing risks analysis.

Main Methods:

  • Review of statistical methodologies for handling competing risks in survival analysis.
  • Comparison of cause-specific hazards models and subdistribution hazards models (Fine and Gray approach).
  • Application of these methods using data from the Chronic Renal Insufficiency Cohort Study, examining fibroblast growth factor 23 and risks of mortality and ESRD.

Main Results:

  • Dependent censoring due to competing risks is prevalent in CKD populations.
  • Cause-specific hazards models and Fine and Gray models offer different perspectives on risk estimation.
  • The choice of method impacts the interpretation of survival data in the presence of competing risks.

Conclusions:

  • Accurate survival analysis in CKD requires explicit consideration of competing risks.
  • Understanding the assumptions and interpretations of different competing risks models is essential for clinical research.
  • Practical recommendations are provided for analyzing and interpreting survival data incorporating competing risks in CKD studies.

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
285
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
677
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
906
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
558
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
674
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
472